Equities
  • Price (EUR)36.10
  • Today's Change0.34 / 0.95%
  • Shares traded156.00
  • 1 Year change-47.62%
  • Beta--
Data delayed at least 20 minutes, as of Nov 28 2022 09:09 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • 0MSD:LSE price falls below 50-day moving average to 35.44 at 08:25 GMT
  • 0MSD:LSE price moved over -1.72% to 34.90
  • 0MSD:LSE price rises above 50-day moving average to 36.08 at 09:19 GMT
  • 0MSD:LSE price rises above 15-day moving average to 36.08 at 09:19 GMT

Key statistics

As of last trade, CompuGroup Medical SE & Co KgaA (0MSD:LSE) traded at 36.10, 17.90% above the 52 week low of 30.62 set on Nov 03, 2022.
52-week range
Today
30.62Nov 03 202272.10Jan 03 2022
Markit short selling activity
Low
Med
High
Open36.27
High--
Low--
Bid34.36
Offer37.96
Previous close35.76
Average volume24.57k
Shares outstanding53.73m
Free float26.71m
P/E (TTM)26.01
Market cap1.94bn EUR
EPS (TTM)1.39
EUR
Annual div (ADY)0.50
EUR
Annual div yield (ADY)1.40%
Div ex-dateMay 20 2022
Div pay-dateMay 24 2022
Data delayed at least 20 minutes, as of Nov 28 2022 09:09 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.